retatrutide clinical trial phase retatrutide Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Retatrutide Dosing Guide: 1-12 mg

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

Dosing is personalized through your selection of formulation and supportive ingredients in consultation with a licensed healthcare provider

Thats also when compounding pharmacies jumped in, making smaller doses available. Another form of microdosing involves taking the full prescribed amount but stretching out the time between shots or skipping a weekly dose entirely

Pathophysiology of inflammatory bowel disease: innate immune system